Business Context and Reporting Period
This Form 8-K is a current report filed by Silo Pharma, Inc. on March 7, 2022. The filing addresses a correction regarding the date of a Special Meeting of Stockholders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to corporate governance events and does not contain financial performance data.
Material Changes
The primary material change disclosed is a correction to the date of the Special Meeting of Stockholders. Previous proxy materials incorrectly stated the meeting would occur on Thursday, March 11, 2022. The company confirms the meeting is scheduled for Friday, March 11, 2022, at 11:00 a.m. Eastern Time.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, management commentary on financial performance, or discussion of risks and contingencies beyond the administrative correction of the meeting date.
Key Facts for Investors to Verify
- Verify the corrected date and time of the Special Meeting of Stockholders: Friday, March 11, 2022, at 11:00 a.m. Eastern Time.
- Confirm the meeting location at 560 Sylvan Avenue, Suite 3160, Englewood Cliffs, NJ 07632.
- Note that this filing does not include financial results or operational updates.